Targeted Delivery of Glypican 3 (GPC3) Antibody-Modified MicroRNA (miR let-7b-5p) Polymer Nanoparticles to Sorafenib-Resistant Hepatsocellular Carcinoma Cells-MedSci.cn

Targeted Delivery of Glypican 3 (GPC3) Antibody-Modified MicroRNA (miR let-7b-5p) Polymer Nanoparticles to Sorafenib-Resistant Hepatsocellular Carcinoma Cells

Zhou, SP; Ma, YF; Liu, XK; Yu, P; Huang, N; Song, L; Xu, RY; Huo, Z; Zhu, T; Tang, XL

Tang, XL (corresponding author), Anhui Univ Sci & Technol, Affiliated Hosp 1, Clin Lab Med, Huainan 232001, Peoples R China.; Tang, XL (corresponding author), Anhui Univ Sci & Technol Wuhu, Inst Environmentally Friendly Mat & Occupat Hlth, Wuhu 241003, Peoples R China.; Tang, XL (corresponding author), Anhui Univ Sci & Technol, Med Sch, Huainan 232001, Peoples R China.

Abstract

The miR let-7b-5p (a kind of microRNAs) has many pathophysiological regulation effects, including human hepatocellular carcinoma (HCC) pathogenesis. T......

Full Text Link

Links

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

Targeted Delivery of Glypican 3 (GPC3) Antibody-Modified MicroRNA (miR let-7b-5p) Polymer Nanoparticles to Sorafenib-Resistant Hepatsocellular Carcinoma Cells

科室

工具

服务